Igor Y. Khandros - May 26, 2022 Form 4 Insider Report for Berkeley Lights, Inc. (CELL)

Role
Director, 10%+ Owner
Signature
/s/ Christine Nassi, Attorney-in-fact for Igor Khandros
Stock symbol
CELL
Transactions as of
May 26, 2022
Transactions value $
$0
Form type
4
Date filed
8/1/2022, 06:45 PM
Previous filing
Sep 9, 2021
Next filing
Jun 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELL Common Stock Award $0 +19.6K +0.22% $0.00 9.01M May 26, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELL Stock Option (Right to Buy) Award $0 +32.3K $0.00 32.3K May 26, 2022 Common Stock 32.3K $4.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 26, 2023.
F2 Consists of (i) 8,840,449 shares held by the Khandros-Bloch Revocable Trust U/A/D 1/24/1997 ("Revocable Trust"), (ii) 19,565 restricted stock units held by the Revocable Trust, (iii) 100,757 shares held by the Khandros 2018 3-Year GRAT (the "Khandros GRAT"), and (iv) 100,757 shares held by the Bloch 2018 3-Year GRAT (the "Bloch GRAT," and together with the Khandros GRAT, the "GRATs"). As co-trustee of the Revocable Trust and the GRATs, Dr. Khandros may be deemed to beneficially own the shares held by the Revocable Trust and the GRATs. Dr. Khandros disclaims beneficial ownership of the shares held by the Revocable Trust and the GRATs except to the extent of his pecuniary interest therein.
F3 The stock options will fully vest on May 26, 2023.